Facebook
Twitter
LinkedIn
ForwardDESCRIPTION
This activity is held weekly on Friday, 7 - 8 a.m. via Zoom Webinar
This weekly internal conference consists of of clinical and surgical interest related to the practice of breast care and includes hospital-based case discussions. Participation from surgery, pathology, radiology, medical oncology, radiation oncology, plastic surgery, medical genetics and general internal medicine - breast clinic, is solicited in the discussion of interpretation of findings, differential diagnosis and management of breast diseases.
TARGET AUDIENCE
The conference is designed for physicians, residents, fellows, mid-level providers and medical students interested in the study of breast disease.
LEARNING OBJECTIVES
Upon conclusion of the activity, participants should be able to:
- Define the advantages/disadvantages of different imaging modalities of the breast
- Discuss different surgical approaches to patients with benign and malignant breast lesions
- Identify new and upcoming chemotherapy regimens available, including clinical trials, for women with breast cancer
- Identify the different radiotherapy options for patients with breast cancer
- Recognize genetic testing options and guidelines for breast cancer and high risk patients
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
None
All relevant financial relationships listed for these individuals have been mitigated.
Deb Blomberg, M.B.A.
Mara Piltin, D.O. (added 5/18/2023)
RaeAnne Boldt
Aparna Kaur, M.D.
Sheila Terrill
Marcia Venegas Pont, M.D.
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. Attendance must be manually recorded in MedHub. Contact MSCGME support staff for assistance.
TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.
COURSE DIRECTORS
Aparna Kaur, M.D.
Marcia Venegas Pont, M.D.
Mara A. Piltin, D.O.
Contact Sheila Terrill at phone (79)2-5140 or Deb Blomberg at phone (79)4-8781.